O	O	0	8	Positive	Positive	B-NP	JJ	O	4	NMOD	O
O	O	9	12	and	and	I-NP	CC	O	4	NMOD	O
O	O	13	21	negative	negative	I-NP	JJ	O	4	NMOD	O
O	O	22	32	regulation	regulation	I-NP	NN	O	0	ROOT	O
O	O	33	35	of	of	B-PP	IN	O	4	NMOD	O
T1	B-Protein	36	47	granulocyte	granulocyte	B-NP	NN	B-DNA	14	NMOD	B-DNA
T1	I-Protein	47	48	-	-	O	HYPH	I-DNA	14	P	I-DNA
T1	I-Protein	48	58	macrophage	macrophage	B-NP	NN	I-DNA	14	NMOD	I-DNA
T1	I-Protein	59	65	colony	colony	I-NP	NN	I-DNA	14	NMOD	I-DNA
T1	I-Protein	65	66	-	-	O	HYPH	I-DNA	14	P	I-DNA
T1	I-Protein	66	77	stimulating	stimulate	B-VP	VBG	I-DNA	14	NMOD	I-DNA
T1	I-Protein	78	84	factor	factor	B-NP	NN	I-DNA	14	NMOD	I-DNA
T25	B-Entity	85	93	promoter	promoter	I-NP	NN	I-DNA	14	NMOD	I-DNA
O	O	94	102	activity	activity	I-NP	NN	O	5	PMOD	O
O	O	103	105	by	by	B-PP	IN	O	4	NMOD	O
O	O	106	110	AML1	AML1	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	110	111	-	-	O	HYPH	O	20	NMOD	O
O	O	111	118	related	relate	B-NP	VBN	O	20	NMOD	O
O	O	119	132	transcription	transcription	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	133	139	factor	factor	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	139	140	,	,	O	,	O	22	P	O
O	O	141	146	PEBP2	PEBP2	B-NP	NN	B-protein	15	PMOD	B-protein
O	O	146	147	.	.	O	.	O	4	P	O

O	O	149	152	The	The	B-NP	DT	O	15	NMOD	O
T2	B-Protein	153	164	granulocyte	granulocyte	I-NP	NN	B-DNA	15	NMOD	B-DNA
T2	I-Protein	164	165	-	-	O	HYPH	I-DNA	15	NMOD	I-DNA
T2	I-Protein	165	175	macrophage	macrophage	B-NP	NN	I-DNA	15	NMOD	I-DNA
T2	I-Protein	176	182	colony	colony	I-NP	NN	I-DNA	15	NMOD	I-DNA
T2	I-Protein	182	183	-	-	O	HYPH	I-DNA	15	NMOD	I-DNA
T2	I-Protein	183	194	stimulating	stimulate	B-VP	VBG	I-DNA	15	NMOD	I-DNA
T2	I-Protein	195	201	factor	factor	B-NP	NN	I-DNA	15	NMOD	I-DNA
O	O	202	203	(	(	O	(	I-DNA	15	NMOD	I-DNA
T3	B-Protein	203	205	GM	GM	B-NP	NN	I-DNA	12	NMOD	I-DNA
T3	I-Protein	205	206	-	-	B-NP	HYPH	I-DNA	12	P	I-DNA
T3	I-Protein	206	209	CSF	CSF	I-NP	NN	I-DNA	15	NMOD	I-DNA
O	O	209	210	)	)	I-NP	)	I-DNA	15	NMOD	I-DNA
O	O	211	215	gene	gene	I-NP	NN	I-DNA	15	NMOD	I-DNA
T26	B-Entity	216	224	promoter	promoter	I-NP	NN	I-DNA	16	SUB	I-DNA
O	O	225	233	contains	contain	B-VP	VBZ	O	0	ROOT	O
O	O	234	235	a	a	B-NP	DT	O	19	NMOD	O
O	O	236	245	consensus	consensus	I-NP	NN	B-DNA	19	NMOD	B-DNA
O	O	246	254	sequence	sequence	I-NP	NN	I-DNA	16	OBJ	I-DNA
O	O	255	258	for	for	B-PP	IN	O	19	NMOD	O
O	O	259	262	the	the	B-NP	DT	O	32	NMOD	O
O	O	263	275	polyomavirus	polyomavirus	I-NP	NN	B-protein	32	NMOD	B-protein
O	O	276	284	enhancer	enhancer	I-NP	NN	I-protein	32	NMOD	I-protein
O	O	285	292	binding	binding	I-NP	NN	I-protein	32	NMOD	I-protein
O	O	292	293	-	-	O	HYPH	I-protein	32	NMOD	I-protein
O	O	293	300	protein	protein	B-NP	NN	I-protein	32	NMOD	I-protein
O	O	301	302	2	2	I-NP	CD	I-protein	32	NMOD	I-protein
O	O	303	304	(	(	O	(	I-protein	32	NMOD	I-protein
O	O	304	309	PEBP2	PEBP2	B-NP	NN	I-protein	32	NMOD	I-protein
O	O	309	310	)	)	O	)	I-protein	32	NMOD	I-protein
O	O	311	324	transcription	transcription	B-NP	NN	I-protein	32	NMOD	I-protein
O	O	325	331	factor	factor	I-NP	NN	I-protein	20	PMOD	I-protein
O	O	331	332	,	,	O	,	O	32	P	O
O	O	333	338	which	which	B-NP	WDT	O	32	NMOD	O
O	O	339	347	consists	consist	B-VP	VBZ	O	34	SBAR	O
O	O	348	350	of	of	B-PP	IN	O	35	VMOD	O
O	O	351	356	alpha	alpha	B-NP	NN	B-protein	40	NMOD	B-protein
O	O	357	360	and	and	O	CC	I-protein	40	NMOD	I-protein
O	O	361	365	beta	beta	B-NP	NN	I-protein	40	NMOD	I-protein
O	O	366	374	subunits	subunit	I-NP	NNS	I-protein	36	PMOD	I-protein
O	O	374	375	.	.	O	.	O	16	P	O

O	O	376	381	There	There	B-NP	EX	O	2	SUB	O
O	O	382	385	are	be	B-VP	VBP	O	0	ROOT	O
O	O	386	388	at	at	B-NP	IN	O	6	NMOD	O
O	O	389	394	least	least	I-NP	JJS	O	3	AMOD	O
O	O	395	398	two	two	I-NP	CD	O	3	AMOD	O
O	O	399	404	genes	gene	I-NP	NNS	O	12	NMOD	O
O	O	404	405	,	,	O	,	O	12	P	O
T27	B-Entity	406	411	alpha	alpha	B-NP	NN	B-DNA	9	NMOD	B-DNA
T27	I-Entity	412	413	A	A	I-NP	NN	I-DNA	12	NMOD	I-DNA
O	O	414	417	and	and	I-NP	CC	O	12	NMOD	O
T28	B-Entity	418	423	alpha	alpha	I-NP	NN	B-DNA	12	NMOD	B-DNA
T28	I-Entity	424	425	B	B	I-NP	NN	I-DNA	2	PRD	I-DNA
O	O	425	426	,	,	O	,	O	12	P	O
O	O	427	435	encoding	encode	B-VP	VBG	O	12	NMOD	O
O	O	436	439	the	the	B-NP	DT	O	17	NMOD	O
O	O	440	445	alpha	alpha	I-NP	NN	B-protein	17	NMOD	B-protein
O	O	446	453	subunit	subunit	I-NP	NN	I-protein	14	OBJ	I-protein
O	O	453	454	.	.	O	.	O	12	NMOD	O
T29	B-Entity	455	460	alpha	alpha	B-NP	NN	B-DNA	20	NMOD	B-DNA
T29	I-Entity	461	462	B	B	I-NP	NN	I-DNA	21	SUB	I-DNA
O	O	463	465	is	be	B-VP	VBZ	O	18	SBAR	O
O	O	466	469	the	the	B-NP	DT	O	24	NMOD	O
T30	B-Entity	470	475	mouse	mouse	I-NP	NN	B-DNA	24	NMOD	B-DNA
T30	I-Entity	476	485	homologue	homologue	I-NP	NN	I-DNA	21	PRD	I-DNA
O	O	486	488	of	of	B-PP	IN	O	24	NMOD	O
O	O	489	494	human	human	B-NP	JJ	B-DNA	28	NMOD	B-DNA
T4	B-Protein	495	499	AML1	AML1	I-NP	NN	I-DNA	28	NMOD	I-DNA
O	O	500	504	gene	gene	I-NP	NN	I-DNA	25	PMOD	I-DNA
O	O	505	513	detected	detect	B-VP	VBN	O	28	NMOD	O
O	O	514	516	at	at	B-PP	IN	O	29	VMOD	O
O	O	517	520	the	the	B-NP	DT	O	32	NMOD	O
O	O	521	532	breakpoints	breakpoint	I-NP	NNS	O	30	PMOD	O
O	O	533	535	of	of	B-PP	IN	O	32	NMOD	O
O	O	536	537	t	t	B-NP	NN	B-DNA	48	NMOD	B-DNA
O	O	537	538	(	(	O	(	I-DNA	34	NMOD	I-DNA
O	O	538	539	8	8	B-NP	CD	I-DNA	34	NMOD	I-DNA
O	O	539	540	;	;	O	:	I-DNA	34	P	I-DNA
O	O	540	542	21	21	B-NP	CD	I-DNA	34	NMOD	I-DNA
O	O	542	543	)	)	O	)	I-DNA	34	NMOD	I-DNA
O	O	544	547	and	and	O	CC	O	48	NMOD	O
O	O	548	549	t	t	B-NP	NN	O	48	NMOD	O
O	O	549	550	(	(	O	(	O	41	NMOD	O
O	O	550	551	3	3	B-NP	CD	O	41	NMOD	O
O	O	551	552	;	;	O	:	O	41	P	O
O	O	552	554	21	21	B-NP	CD	O	41	NMOD	O
O	O	554	555	)	)	O	)	O	41	NMOD	O
O	O	556	563	myeloid	myeloid	B-NP	JJ	O	48	NMOD	O
O	O	564	573	leukemias	leukemia	I-NP	NNS	O	33	PMOD	O
O	O	573	574	.	.	O	.	O	2	P	O

O	O	575	577	We	We	B-NP	PRP	O	2	SUB	O
O	O	578	586	examined	examine	B-VP	VBD	O	0	ROOT	O
T5	B-Protein	587	592	alpha	alpha	B-NP	NN	B-protein	4	NMOD	B-protein
T5	I-Protein	593	595	A1	A1	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	596	597	(	(	O	(	O	12	DEP	O
O	O	597	599	an	an	B-NP	DT	O	11	NMOD	O
T31	B-Entity	600	605	alpha	alpha	I-NP	NN	B-protein	8	NMOD	B-protein
T31	I-Entity	606	607	A	A	I-NP	NN	I-protein	11	NMOD	I-protein
T31	I-Entity	607	608	-	-	I-NP	HYPH	O	11	P	O
T31	I-Entity	608	612	gene	gene	I-NP	NN	O	11	NMOD	O
O	O	613	620	product	product	I-NP	NN	O	12	DEP	O
O	O	620	621	)	)	O	)	O	4	NMOD	O
O	O	622	625	and	and	O	CC	O	18	NMOD	O
T6	B-Protein	626	631	alpha	alpha	B-NP	NN	B-protein	15	NMOD	B-protein
T6	I-Protein	632	634	B1	B1	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	635	638	and	and	O	CC	O	18	NMOD	O
T7	B-Protein	639	644	alpha	alpha	B-NP	NN	B-protein	18	NMOD	B-protein
T7	I-Protein	645	647	B2	B2	I-NP	NN	I-protein	2	OBJ	I-protein
O	O	648	649	(	(	O	(	O	26	DEP	O
O	O	649	652	two	two	B-NP	CD	O	25	NMOD	O
T32	B-Entity	653	658	alpha	alpha	I-NP	SYM	B-DNA	22	NMOD	B-DNA
T32	I-Entity	659	660	B	B	I-NP	NN	I-DNA	25	NMOD	I-DNA
O	O	660	661	-	-	B-NP	HYPH	O	25	P	O
O	O	661	668	encoded	encode	I-NP	VBN	O	25	NMOD	O
O	O	669	676	isomers	isomer	I-NP	NNS	O	26	DEP	O
O	O	676	677	)	)	O	)	O	18	NMOD	O
O	O	678	681	for	for	B-PP	IN	O	18	NMOD	O
O	O	682	687	their	their	B-NP	PRP$	O	29	NMOD	O
O	O	688	695	effects	effect	I-NP	NNS	O	27	PMOD	O
O	O	696	698	on	on	B-PP	IN	O	29	NMOD	O
O	O	699	702	the	the	B-NP	DT	O	35	NMOD	O
T8	B-Protein	703	705	GM	GM	I-NP	NNP	O	35	NMOD	O
T8	I-Protein	705	706	-	-	I-NP	HYPH	O	35	NMOD	O
T8	I-Protein	706	709	CSF	CSF	I-NP	NN	B-DNA	35	NMOD	B-DNA
T33	B-Entity	710	718	promoter	promoter	I-NP	NN	I-DNA	30	PMOD	I-DNA
O	O	718	719	.	.	O	.	O	2	P	O

T9	B-Protein	720	725	PEBP2	PEBP2	B-NP	NN	B-protein	3	NMOD	B-protein
T9	I-Protein	726	731	alpha	alpha	I-NP	NN	I-protein	3	NMOD	I-protein
T9	I-Protein	732	734	A1	A1	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	734	735	,	,	O	,	O	11	P	O
T10	B-Protein	736	741	alpha	alpha	B-NP	NN	B-protein	6	NMOD	B-protein
T10	I-Protein	742	744	B1	B1	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	744	745	,	,	O	,	O	11	P	O
O	O	746	749	and	and	O	CC	O	11	NMOD	O
T11	B-Protein	750	755	alpha	alpha	B-NP	NN	B-protein	11	NMOD	B-protein
T11	I-Protein	756	758	B2	B2	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	759	767	proteins	protein	I-NP	NNS	I-protein	12	SUB	I-protein
O	O	768	773	bound	bind	B-VP	VBD	O	0	ROOT	O
O	O	774	777	the	the	B-NP	DT	O	15	NMOD	O
T34	B-Entity	778	783	PEBP2	PEBP2	I-NP	NN	B-DNA	15	NMOD	B-DNA
T34	I-Entity	784	788	site	site	I-NP	NN	I-DNA	12	OBJ	I-DNA
O	O	789	795	within	within	B-PP	IN	O	15	NMOD	O
O	O	796	799	the	the	B-NP	DT	O	22	NMOD	O
O	O	800	805	mouse	mouse	I-NP	NN	B-DNA	22	NMOD	B-DNA
T12	B-Protein	806	808	GM	GM	I-NP	NNP	I-DNA	22	NMOD	I-DNA
T12	I-Protein	808	809	-	-	I-NP	HYPH	I-DNA	22	NMOD	I-DNA
T12	I-Protein	809	812	CSF	CSF	I-NP	NN	I-DNA	22	NMOD	I-DNA
T35	B-Entity	813	821	promoter	promoter	I-NP	NN	I-DNA	16	PMOD	I-DNA
O	O	821	822	.	.	O	.	O	12	P	O

T13	B-Protein	823	828	PEBP2	PEBP2	B-NP	NN	B-protein	3	NMOD	B-protein
T13	I-Protein	829	834	alpha	alpha	I-NP	NN	I-protein	3	NMOD	I-protein
T13	I-Protein	835	837	A1	A1	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	838	841	and	and	O	CC	O	6	NMOD	O
T14	B-Protein	842	847	alpha	alpha	B-NP	NN	B-protein	6	NMOD	B-protein
T14	I-Protein	848	850	B1	B1	I-NP	NN	I-protein	7	SUB	I-protein
O	O	851	859	enhanced	enhance	B-VP	VBD	O	0	ROOT	O
O	O	860	863	the	the	B-NP	DT	O	9	NMOD	O
O	O	864	874	expression	expression	I-NP	NN	O	7	OBJ	O
O	O	875	877	of	of	B-PP	IN	O	9	NMOD	O
O	O	878	881	the	the	B-NP	DT	O	10	PMOD	O
T15	B-Protein	882	884	GM	GM	I-NP	NNP	O	11	DEP	O
T15	I-Protein	884	885	-	-	I-NP	HYPH	O	12	PMOD	O
T15	I-Protein	885	888	CSF	CSF	I-NP	NN	B-DNA	15	NMOD	B-DNA
T36	B-Entity	889	897	promoter	promoter	I-NP	NN	I-DNA	13	PMOD	I-DNA
O	O	897	898	-	-	B-VP	HYPH	O	15	NMOD	O
O	O	898	904	driven	drive	B-NP	VBN	O	19	NMOD	O
O	O	905	913	reporter	reporter	I-NP	NN	B-DNA	19	NMOD	B-DNA
O	O	914	921	plasmid	plasmid	I-NP	NN	I-DNA	16	OBJ	I-DNA
O	O	922	924	in	in	B-PP	IN	O	19	NMOD	O
O	O	925	937	unstimulated	unstimulated	B-NP	JJ	O	38	NMOD	O
O	O	938	941	and	and	I-NP	CC	O	38	NMOD	O
O	O	942	944	12	12	I-NP	CD	O	38	NMOD	O
O	O	944	945	-	-	I-NP	HYPH	O	38	P	O
O	O	945	946	O	O	I-NP	NN	B-DNA	27	NMOD	B-DNA
O	O	946	947	-	-	O	HYPH	I-DNA	27	P	I-DNA
O	O	947	967	tetradecanoylphorbol	tetradecanoylphorbol	B-NP	NN	I-DNA	38	NMOD	I-DNA
O	O	968	970	13	13	I-NP	CD	I-DNA	27	NMOD	I-DNA
O	O	970	971	-	-	I-NP	HYPH	O	27	P	O
O	O	971	978	acetate	acetate	I-NP	NN	O	38	NMOD	O
O	O	978	979	/	/	B-NP	SYM	O	38	P	O
T16	B-Protein	979	997	phytohemagglutinin	phytohemagglutinin	I-NP	NN	B-protein	38	NMOD	B-protein
O	O	997	998	-	-	B-VP	HYPH	O	38	P	O
O	O	998	1008	stimulated	stimulate	B-NP	VBN	O	38	NMOD	O
O	O	1009	1014	human	human	I-NP	JJ	B-cell_line	38	NMOD	B-cell_line
O	O	1015	1021	Jurkat	Jurkat	I-NP	NN	I-cell_line	38	NMOD	I-cell_line
O	O	1022	1023	T	T	I-NP	NN	I-cell_line	38	NMOD	I-cell_line
O	O	1024	1029	cells	cell	I-NP	NNS	I-cell_line	20	PMOD	I-cell_line
O	O	1029	1030	.	.	O	.	O	7	P	O

O	O	1031	1033	In	In	B-PP	IN	O	7	VMOD	O
O	O	1034	1042	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	1042	1043	,	,	O	,	O	7	P	O
O	O	1044	1047	the	the	B-NP	DT	O	6	NMOD	O
O	O	1048	1056	promoter	promoter	I-NP	NN	O	6	NMOD	O
O	O	1057	1065	activity	activity	I-NP	NN	O	7	SUB	O
O	O	1066	1069	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1070	1080	suppressed	suppress	I-VP	VBN	O	7	VC	O
O	O	1081	1083	by	by	B-PP	IN	O	8	VMOD	O
T17	B-Protein	1084	1089	alpha	alpha	B-NP	NN	B-protein	11	NMOD	B-protein
T17	I-Protein	1090	1092	B2	B2	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	1092	1093	.	.	O	.	O	7	P	O

O	O	1094	1106	Coexpression	Coexpression	B-NP	NN	O	8	SUB	O
O	O	1107	1109	of	of	B-PP	IN	O	1	NMOD	O
T18	B-Protein	1110	1115	alpha	alpha	B-NP	NN	B-protein	4	NMOD	B-protein
T18	I-Protein	1116	1118	B1	B1	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	1119	1122	and	and	O	CC	O	7	NMOD	O
T19	B-Protein	1123	1128	alpha	alpha	B-NP	NN	B-protein	7	NMOD	B-protein
T19	I-Protein	1129	1131	B2	B2	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	1132	1138	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	1139	1143	that	that	B-SBAR	IN	O	8	VMOD	O
O	O	1144	1147	the	the	B-NP	DT	O	12	NMOD	O
O	O	1148	1156	promoter	promoter	I-NP	NN	O	12	NMOD	O
O	O	1157	1165	activity	activity	I-NP	NN	O	13	SUB	O
O	O	1166	1171	could	could	B-VP	MD	O	9	SBAR	O
O	O	1172	1174	be	be	I-VP	VB	O	13	VC	O
O	O	1175	1185	determined	determine	I-VP	VBN	O	14	VC	O
O	O	1186	1188	by	by	B-PP	IN	O	15	VMOD	O
O	O	1189	1192	the	the	B-NP	DT	O	23	NMOD	O
T20	B-Protein	1193	1198	alpha	alpha	I-NP	SYM	B-protein	19	NMOD	B-protein
T20	I-Protein	1199	1201	B1	B1	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	1201	1202	/	/	O	SYM	O	23	P	O
T21	B-Protein	1202	1207	alpha	alpha	B-NP	NN	B-protein	23	NMOD	B-protein
T21	I-Protein	1208	1210	B2	B2	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	1211	1216	ratio	ratio	I-NP	NN	O	16	PMOD	O
O	O	1216	1217	.	.	O	.	O	8	P	O

O	O	1218	1224	Jurkat	Jurkat	B-NP	NN	O	3	NMOD	O
O	O	1225	1229	cell	cell	I-NP	NN	O	3	NMOD	O
O	O	1230	1237	extract	extract	I-NP	NN	O	4	SUB	O
O	O	1238	1247	contained	contain	B-VP	VBD	O	0	ROOT	O
O	O	1248	1253	PEBP2	PEBP2	B-NP	NN	B-DNA	6	NMOD	B-DNA
O	O	1254	1258	site	site	I-NP	NN	I-DNA	11	NMOD	I-DNA
O	O	1258	1259	-	-	B-VP	HYPH	O	11	P	O
O	O	1259	1266	binding	bind	B-NP	VBG	O	11	NMOD	O
O	O	1267	1274	protein	protein	I-NP	NN	O	11	NMOD	O
O	O	1274	1275	(	(	I-NP	(	O	11	NMOD	O
O	O	1275	1276	s	s	I-NP	NNS	O	4	OBJ	O
O	O	1276	1277	)	)	O	)	O	11	NMOD	O
O	O	1278	1282	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	1283	1288	cross	cross	B-NP	AFX	O	16	VMOD	O
O	O	1288	1289	-	-	I-NP	HYPH	O	16	P	O
O	O	1289	1296	reacted	react	B-VP	VBD	O	13	SBAR	O
O	O	1297	1301	with	with	B-PP	IN	O	16	VMOD	O
O	O	1302	1311	antimouse	antimouse	B-NP	JJ	B-protein	21	NMOD	B-protein
T22	B-Protein	1312	1317	alpha	alpha	I-NP	NN	I-protein	21	NMOD	I-protein
T22	I-Protein	1318	1320	A1	A1	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	1321	1331	antibodies	antibody	I-NP	NNS	I-protein	17	PMOD	I-protein
O	O	1331	1332	.	.	O	.	O	4	P	O

O	O	1333	1341	Northern	Northern	B-NP	NN	O	3	NMOD	O
O	O	1342	1346	blot	blot	I-NP	NN	O	3	NMOD	O
O	O	1347	1355	analysis	analysis	I-NP	NN	O	4	SUB	O
O	O	1356	1365	indicated	indicate	B-VP	VBD	O	0	ROOT	O
O	O	1366	1369	the	the	B-NP	DT	O	6	NMOD	O
O	O	1370	1380	expression	expression	I-NP	NN	O	4	OBJ	O
O	O	1381	1383	of	of	B-PP	IN	O	6	NMOD	O
O	O	1384	1389	human	human	B-NP	JJ	B-protein	21	NMOD	B-protein
O	O	1390	1395	PEBP2	PEBP2	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	1396	1401	alpha	alpha	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	1402	1403	A	A	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	1403	1404	,	,	O	,	O	21	P	O
O	O	1405	1410	alpha	alpha	B-NP	NN	B-DNA	14	NMOD	B-DNA
O	O	1411	1412	B	B	I-NP	NN	I-DNA	21	NMOD	I-DNA
T23	B-Protein	1413	1414	(	(	O	(	O	17	DEP	O
T23	I-Protein	1414	1418	AML1	AML1	B-NP	NN	B-protein	17	DEP	B-protein
T23	I-Protein	1418	1419	)	)	O	)	O	14	NMOD	O
O	O	1419	1420	,	,	O	,	O	21	P	O
O	O	1421	1424	and	and	O	CC	O	21	NMOD	O
O	O	1425	1429	beta	beta	B-NP	NN	B-DNA	21	NMOD	B-DNA
O	O	1430	1435	genes	gene	I-NP	NNS	I-DNA	7	PMOD	I-DNA
O	O	1436	1438	in	in	B-PP	IN	O	6	NMOD	O
O	O	1439	1445	Jurkat	Jurkat	B-NP	NN	B-cell_line	24	NMOD	B-cell_line
O	O	1446	1451	cells	cell	I-NP	NNS	I-cell_line	22	PMOD	I-cell_line
O	O	1451	1452	.	.	O	.	O	4	P	O

O	O	1453	1461	Although	Although	B-SBAR	IN	O	24	VMOD	O
O	O	1462	1469	further	further	B-NP	JJ	O	3	NMOD	O
O	O	1470	1477	studies	study	I-NP	NNS	O	4	SUB	O
O	O	1478	1481	are	be	B-VP	VBP	O	1	SBAR	O
O	O	1482	1490	required	require	I-VP	VBN	O	4	VC	O
O	O	1491	1493	to	to	B-VP	TO	O	7	VMOD	O
O	O	1494	1503	determine	determine	I-VP	VB	O	4	VMOD	O
O	O	1504	1507	the	the	B-NP	DT	O	10	NMOD	O
O	O	1508	1515	precise	precise	I-NP	JJ	O	10	NMOD	O
O	O	1516	1520	role	role	I-NP	NN	O	7	OBJ	O
O	O	1521	1523	of	of	B-PP	IN	O	10	NMOD	O
O	O	1524	1529	PEBP2	PEBP2	B-NP	NN	B-protein	11	PMOD	B-protein
O	O	1530	1532	in	in	B-PP	IN	O	10	NMOD	O
O	O	1533	1536	the	the	B-NP	DT	O	19	NMOD	O
T24	B-Protein	1537	1539	GM	GM	I-NP	NNP	O	19	NMOD	O
T24	I-Protein	1539	1540	-	-	I-NP	HYPH	O	19	NMOD	O
T24	I-Protein	1540	1543	CSF	CSF	I-NP	NN	B-DNA	19	NMOD	B-DNA
T37	B-Entity	1544	1552	promoter	promoter	I-NP	NN	I-DNA	19	NMOD	I-DNA
O	O	1553	1561	activity	activity	I-NP	NN	O	13	PMOD	O
O	O	1561	1562	,	,	O	,	O	24	P	O
O	O	1563	1566	the	the	B-NP	DT	O	23	NMOD	O
O	O	1567	1574	present	present	I-NP	JJ	O	23	NMOD	O
O	O	1575	1583	findings	finding	I-NP	NNS	O	24	SUB	O
O	O	1584	1593	suggested	suggest	B-VP	VBD	O	0	ROOT	O
O	O	1594	1597	the	the	B-NP	DT	O	26	NMOD	O
O	O	1598	1608	importance	importance	I-NP	NN	O	24	OBJ	O
O	O	1609	1611	of	of	B-PP	IN	O	26	NMOD	O
O	O	1612	1615	the	the	B-NP	DT	O	30	NMOD	O
O	O	1616	1624	relative	relative	I-NP	JJ	O	30	NMOD	O
O	O	1625	1630	ratio	ratio	I-NP	NN	O	27	PMOD	O
O	O	1631	1633	of	of	B-PP	IN	O	30	NMOD	O
O	O	1634	1643	different	different	B-NP	JJ	O	31	PMOD	O
O	O	1644	1649	PEBP2	PEBP2	I-NP	NN	B-protein	34	NMOD	B-protein
O	O	1650	1658	isoforms	isoform	I-NP	NNS	I-protein	32	NMOD	I-protein
O	O	1659	1661	in	in	B-PP	IN	O	26	NMOD	O
O	O	1662	1672	regulating	regulate	B-VP	VBG	O	35	PMOD	O
O	O	1673	1676	the	the	B-NP	DT	O	38	NMOD	O
O	O	1677	1683	levels	level	I-NP	NNS	O	36	OBJ	O
O	O	1684	1686	of	of	B-PP	IN	O	38	NMOD	O
O	O	1687	1690	the	the	B-NP	DT	O	42	NMOD	O
O	O	1691	1699	promoter	promoter	I-NP	NN	O	42	NMOD	O
O	O	1700	1708	activity	activity	I-NP	NN	O	39	PMOD	O
O	O	1708	1709	.	.	O	.	O	24	P	O
